ESR2 and breast cancer: Rowlands et al. [32] found that soyasapogenol A had estrogenic activity and could inhibit the proliferation of breast cancer cell line MDA-MB-231 (ERα−/ERβ+), but it was uncertain whether this effect was through direct or indirect activation of ER.